- Brook I. Otitis media: microbiology and management. J Otolaryngol 1994; 23: 269–75.
- Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 1998; 17: 986–91.
- Phillips EJ, Simor AE. Bacterial meningitis in children and adults. Postgrad Med 1998; 103: 102–17.
- Conception NF, Frasch CE. Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcalpolysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2001; 8: 266–72.
- ACIP. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices. MMWR 1997; 46: 1–24.
- Hausdorff WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001; 357: 950–2.
- Eriksson M, Henriques B, Ekdahl K. Epidemiology of pneumococcal infections in Swedish children. Acta Paediatr Suppl 2000; 435: 35–9.
- Burman LÅ, Norrby SR, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985; 7: 133–42.
- Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995; 33: 2759–62.
- Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453–60.
- Robbins JB, Austrian R, Lee C-J, Rastogi S, Schiffman G, Henrichsen J, et al. Considerations for formulating the second generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types. J Infect Dis 1983; 148: 1136–59.
- Henriques Normark B, Kalin M, Örtqvist A, Åkerlund T, Olsson Liljequist B, et al. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis 2001; 184: 861–9.
- Sniadack DH, Schwartz B, Lipman H, Bogaertes J, Butler JC, Dagan R, et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children – implications for vaccine strategies. Pediatr Infect Dis J 1995; 14: 503–10.
- Scott JA, Hall AJ, Dagan R, Dixon JMS, Eykun SJ, Fenoll A, et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis 1996; 22: 973–81.
- Hausdorff WP, Bryant J, Paradiso PR, Siber G. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulations and use, part I. Clin Infect Dis 2000; 30: 100–21.
- Henriques Normark B, Örtqvist A, Kalin M, Olsson-Liljequist B, Hedlund J, Svenson SB, Kallenius G. Changes in serotype distribution may hamper efficacy of pneumococcal conjugate vaccines in children. Scand J Infect Dis 2001; 33: 848–50.
- Halbert SP, Swick L, Sonn C. The use of precipitin analysis in agar for the study of human streptococcal infections. II. Ouchterlony and Oakley techniques. J Exp Med 1955; 101: 557–76.
- Lund E, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. In: Bergan T, Norris JR, eds. Methods in microbiology. Vol 12. New York: Academic Press; 1978. p. 241–62.
- Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166: 374–82.
- Robbins JB, Lee C-J, Rastogi SC, Schiffman G, Henrichsen J. Comparative immunogenicity of group 6 pneumococcal type 6A (6) and type 6B (26) capsular polysaccharides. Infect Immun 1979; 26: 1116–22.
- Butler JC. Epidemiology of pneumococcal serotypes and conjugate vaccine formulation. Microb Drug Resist 1997; 3: 125–9.
- Eskola J, Takala AK, Kela E, Pekkanen E, Kallikoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in Finland. JAMA 1992; 268: 3323–7.
- Nielsen SV, Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982–1987. Clin Infect Dis 1992; 15: 794–8.
- Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber G. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000; 30: 122–40.
- Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978–1994: implications for development of a conjugate vaccine. J Infect Dis 1995; 171: 885–9.
- Hedlund J, Svenson SB, Kalin M, Henrichsen J, Olsson-Liljequist B, Möllerberg G, Kallenius G. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis 1995; 21: 948–53.
- Jacobs NM, Lerdkachornsuk S, Metzger WI. Pneumococcal bacteremia in infants and children: a ten-year experience at the cook country hospital with special reference to the pneumococcal serotypes isolated. Pediatrics 1979; 64: 296–300.
- Loda FA, Collier AM, Glezen WP, Strangert K, Clyde WA, Denny FW. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr 1975; 87: 1087–93.
- Kamme C, Ekdahl K, Mölstad S. Penicillin-resistant pneumococci in southern Sweden, 1993–1997. Microb Drug Resist 1999; 5: 31–6.
Scandinavian Journal of Infectious Diseases
Volume 35, 2003 - Issue 8